NEW YORK (GenomeWeb News) — Beckman Coulter closed its tender offer for $235 million in senior notes at the end of business yesterday, the company said today.
 
The company said the money raised from the offering would go toward paying debts, a large chunk of which coming from the acquisition of Lumigen, and it would use the rest of the funds to pay debts and fund research.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.